2016
DOI: 10.5935/0034-7280.20160019
|View full text |Cite
|
Sign up to set email alerts
|

Corneal collagen cross-linking for progressive keratoconus in patients aged 9 to 14

Abstract: P urpose: To determ ine the safety and efficacy of corneal collagen cross-linking (C X L ) for progressive keratoconus in patients aged betw een 9 and 14 years old. M ethods: Sixteen eyes of 11 patients (8 m ale and 3 fem ale) w ith progressive keratoconus underw ent epithelium -off C X L according to the standard D resden protocol. M ean follow -up w as 26 m onths (range, 12 to 60 m onths). P re-and postoperative exam inations included: uncorrected visual acuity (U C V A ), best spectacle-corrected visual acu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 20 publications
(30 reference statements)
0
1
0
1
Order By: Relevance
“…In the pediatric population, KC progression has been reported to be between 0% and 35% despite epithelium-off CXL treatment. 2,5–13(p14),14–41 However, the criteria for analyzing outcomes are not standardized across these studies, making it challenging to assess CXL outcomes (see Supplemental Table 1, Supplemental Digital Content 1, http://links.lww.com/ICO/B235). Although several systematic analyses were published on clinical outcome improvement after CXL in the pediatric KC population, they did not directly study CXL failure rate.…”
mentioning
confidence: 99%
“…In the pediatric population, KC progression has been reported to be between 0% and 35% despite epithelium-off CXL treatment. 2,5–13(p14),14–41 However, the criteria for analyzing outcomes are not standardized across these studies, making it challenging to assess CXL outcomes (see Supplemental Table 1, Supplemental Digital Content 1, http://links.lww.com/ICO/B235). Although several systematic analyses were published on clinical outcome improvement after CXL in the pediatric KC population, they did not directly study CXL failure rate.…”
mentioning
confidence: 99%
“…Além disso, pode estar mais presente na segunda década de vida, tendo como consequência a diminuição da acuidade visual de forma progressiva. O paciente acometido por ceratocone manifestará, além de deficiências visuais, miopia e astigmatismo, que tem sua gravidade aumentada com o passar do tempo (DINIZ ER, et al, 2021;PALIS FP, et al, 2016).…”
Section: Introductionunclassified